{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Murphy CN"],"funding":["National Health and Medical Research Council"],"pagination":["901"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8877863"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(4)"],"pubmed_abstract":["Fetal growth restriction (FGR), when undetected antenatally, is the biggest risk factor for preventable stillbirth. Maternal circulating SPINT1 is reduced in pregnancies, which ultimately deliver small for gestational age (SGA) infants at term (birthweight < 10th centile), compared to appropriate for gestational age (AGA) infants (birthweight ≥ 10th centile). SPINT1 is also reduced in FGR diagnosed before 34 weeks' gestation. We hypothesised that circulating SPINT1 would be decreased in co-existing preterm preeclampsia and FGR. Plasma SPINT1 was measured in samples obtained from two double-blind, randomised therapeutic trials. In the Preeclampsia Intervention with Esomeprazole trial, circulating SPINT1 was decreased in women with preeclampsia who delivered SGA infants (n = 75, median = 18,"],"journal":["Journal of clinical medicine"],"pubmed_title":["Circulating SPINT1 Is Reduced in a Preeclamptic Cohort with Co-Existing Fetal Growth Restriction."],"pmcid":["PMC8877863"],"funding_grant_id":["#1065854","#20000732","#116071","#1136418","#1159261","#1146128","#1176922"],"pubmed_authors":["Murphy CN","Tong S","MacDonald TM","Cluver CA","Keenan E","Walker SP","Hastie R","Kaitu'u-Lino TJ","Hannan NJ","Brownfoot FC","Cannon P"],"additional_accession":[]},"is_claimable":false,"name":"Circulating SPINT1 Is Reduced in a Preeclamptic Cohort with Co-Existing Fetal Growth Restriction.","description":"Fetal growth restriction (FGR), when undetected antenatally, is the biggest risk factor for preventable stillbirth. Maternal circulating SPINT1 is reduced in pregnancies, which ultimately deliver small for gestational age (SGA) infants at term (birthweight < 10th centile), compared to appropriate for gestational age (AGA) infants (birthweight ≥ 10th centile). SPINT1 is also reduced in FGR diagnosed before 34 weeks' gestation. We hypothesised that circulating SPINT1 would be decreased in co-existing preterm preeclampsia and FGR. Plasma SPINT1 was measured in samples obtained from two double-blind, randomised therapeutic trials. In the Preeclampsia Intervention with Esomeprazole trial, circulating SPINT1 was decreased in women with preeclampsia who delivered SGA infants (n = 75, median = 18,","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2025-04-04T09:00:44.286Z","creation":"2025-04-04T09:00:44.286Z"},"accession":"S-EPMC8877863","cross_references":{"pubmed":["35207174"],"doi":["10.3390/jcm11040901"]}}